The Mechanisms Shaping the Repertoire of CD4(+)Foxp3(+)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
AIRE Variations in Addison's Disease and Autoimmune Polyendocrine Syndromes
Genes and Immunity (2008) 9, 130–136 & 2008 Nature Publishing Group All rights reserved 1466-4879/08 $30.00 www.nature.com/gene ORIGINAL ARTICLE AIRE variations in Addison’s disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I AS Bøe Wolff1,2,3,7, B Oftedal1,2,7, S Johansson3,4, O Bruland3, K Løva˚s1,2, A Meager5, C Pedersen6, ES Husebye1,2 and PM Knappskog3,4 1Institute of Medicine, University of Bergen, Bergen, Norway; 2Department of Medicine, Haukeland University Hospital, Bergen, Norway; 3Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway; 4Department of Clinical Medicine, University of Bergen, Bergen, Norway; 5Biotherapeutics Group, The National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Herts, UK and 6Department of Pediatrics, Kolding Hospital, Kolding, Denmark Autoimmune Addison’s disease (AAD) is often associated with other components in autoimmune polyendocrine syndromes (APS). Whereas APS I is caused by mutations in the AIRE gene, the susceptibility genes for AAD and APS II are unclear. In the present study, we investigated whether polymorphisms or copy number variations in the AIRE gene were associated with AAD and APS II. First, nine SNPs in the AIRE gene were analyzed in 311 patients with AAD and APS II and 521 healthy controls, identifying no associated risk. Second, in a subgroup of 25 of these patients, AIRE sequencing revealed three novel polymorphisms. Finally, the AIRE copy number was determined by duplex quantitative PCR in 14 patients with APS I, 161 patients with AAD and APS II and in 39 healthy subjects. -
Sexual Dimorphism in the Immune Response: Endocrinologic and Genetic Insights
RIJKSUNIVERSITEIT GRONINGEN Sexual dimorphism in the immune response: endocrinologic and genetic insights Author: Lisa Wanders Supervisor: Dr. M.M. Faas Master-essay 29.05.2016 Sexual dimorphism in the immune response: endocrinologic and genetic insights Author: Lisa Wanders Supervisor: Dr. M.M. Faas Group: Medical Biology Abstract Differences in the immune response exist between men and women. While females have a stronger adaptive immune response, including the cellular and humoral response, males have a stronger and more sensitive innate immune response. This essay reviews these differences and focuses on sex hormones and genetics as possible underlying causes. The implications for a variety of conditions are discussed. Females have a higher predisposition to acquire autoimmune diseases and are more susceptible to acute graft rejections but are at the same time more resistant to infections and gain better protection from vaccinations. Males on the other hand have a higher risk to develop multiple organ failure after trauma and severe infections after surgery. Moreover, higher rates of sepsis are observed in males compared to females. Despite extensive research in this field, many of the mechanisms underlying the sexual dimorphism in the immune response are still unknown. 1 Table of contents 1. Introduction ..................................................................................................................................... 3 2. Sex-based differences in the immune response ............................................................................ -
Ncounter® Mouse Autoimmune Profiling Panel - Gene and Probe Details
nCounter® Mouse AutoImmune Profiling Panel - Gene and Probe Details Official Symbol Accession Alias / Previous Symbol Official Full Name Other targets or Isoform Information AW208573,CD143,expressed sequence AW208573,MGD-MRK- Ace NM_009598.1 1032,MGI:2144508 angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 2610036I19Rik,2610510L13Rik,Acinus,apoptotic chromatin condensation inducer in the nucleus,C79325,expressed sequence C79325,MGI:1913562,MGI:1919776,MGI:2145862,mKIAA0670,RIKEN cDNA Acin1 NM_001085472.2 2610036I19 gene,RIKEN cDNA 2610510L13 gene apoptotic chromatin condensation inducer 1 Acp5 NM_001102405.1 MGD-MRK-1052,TRACP,TRAP acid phosphatase 5, tartrate resistant 2310066K23Rik,AA960180,AI851923,Arp1b,expressed sequence AA960180,expressed sequence AI851923,MGI:2138136,MGI:2138359,RIKEN Actr1b NM_146107.2 cDNA 2310066K23 gene ARP1 actin-related protein 1B, centractin beta Adam17 NM_001277266.1 CD156b,Tace,tumor necrosis factor-alpha converting enzyme a disintegrin and metallopeptidase domain 17 ADAR1,Adar1p110,Adar1p150,AV242451,expressed sequence Adar NM_001038587.3 AV242451,MGI:2139942,mZaADAR adenosine deaminase, RNA-specific Adora2a NM_009630.2 A2AAR,A2aR,A2a, Rs,AA2AR,MGD-MRK-16163 adenosine A2a receptor Ager NM_007425.2 RAGE advanced glycosylation end product-specific receptor AI265500,angiotensin precursor,Aogen,expressed sequence AI265500,MGD- Agt NM_007428.3 MRK-1192,MGI:2142488,Serpina8 angiotensinogen (serpin peptidase inhibitor, clade A, member 8) Ah,Ahh,Ahre,aromatic hydrocarbon responsiveness,aryl hydrocarbon -
Our Environment Shapes Us: the Importance of Environment and Sex Differences in Regulation of Autoantibody Production
REVIEW published: 08 March 2018 doi: 10.3389/fimmu.2018.00478 Our Environment Shapes Us: The Importance of Environment and Sex Differences in Regulation of Autoantibody Production Michael Edwards, Rujuan Dai and S. Ansar Ahmed* Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, United States Consequential differences exist between the male and female immune systems’ ability to respond to pathogens, environmental insults or self-antigens, and subsequent effects on immunoregulation. In general, females when compared with their male counterparts, respond to pathogenic stimuli and vaccines more robustly, with heightened production of antibodies, pro-inflammatory cytokines, and chemokines. While the precise reasons for sex differences in immune response to different stimuli are not yet well understood, females are more resistant to infectious diseases and much more likely to develop auto- Edited by: Ralf J. Ludwig, immune diseases. Intrinsic (i.e., sex hormones, sex chromosomes, etc.) and extrinsic University of Lübeck, (microbiome composition, external triggers, and immune modulators) factors appear to Germany impact the overall outcome of immune responses between sexes. Evidence suggests Reviewed by: Ayanabha Chakraborti, that interactions between environmental contaminants [e.g., endocrine disrupting chemi- University of Alabama at cals (EDCs)] and host leukocytes affect the ability of the immune system to mount a Birmingham, United States response to exogenous and endogenous insults, and/or return to normal activity following Jun-ichi Kira, Kyushu University, Japan clearance of the threat. Inherently, males and females have differential immune response Maja Wallberg, to external triggers. In this review, we describe how environmental chemicals, including University of Cambridge, United Kingdom EDCs, may have sex differential influence on the outcome of immune responses through *Correspondence: alterations in epigenetic status (such as modulation of microRNA expression, gene S. -
Regulatory Lymphocytes: the Dice That Resolve the Tumor Endgame Subhadip Pati, Anandi Chowdhury, Sumon Mukherjee, Aharna Guin, Shravanti Mukherjee and Gaurisankar Sa*
Pati et al. Applied Cancer Research (2020) 40:7 Applied Cancer Research https://doi.org/10.1186/s41241-020-00091-0 REVIEW Open Access Regulatory lymphocytes: the dice that resolve the tumor endgame Subhadip Pati, Anandi Chowdhury, Sumon Mukherjee, Aharna Guin, Shravanti Mukherjee and Gaurisankar Sa* Abstract A large number of cancer patients relapse after chemotherapeutic treatment. The immune system is capable of identifying and destroying cancer cells, so recent studies have highlighted the growing importance of using combinatorial chemotherapy and immunotherapy. However, many patients have innate or acquired resistance to immunotherapies. Long-term follow-up in a pooled meta-analysis exhibited long-term survival in approximately 20% of patients treated with immune checkpoint inhibitors or the adoptive transfer of chimeric T cells. It has been reported that high levels of immunoregulatory cells in cancer patients contribute to immunotherapy resistance via immunosuppression. Among the most important regulatory cell subtypes are the CD4+ T-regulatory cells (Tregs), identified by their expression of the well-characterized, lineage-specific transcription factor FOXP3. In addition to CD4+ Tregs, other regulatory cells present in the tumor microenvironment, namely CD8+ Tregs and IL10-producing B-regulatory cells (Bregs) that also modulate the immune response in solid and lymphoid tumors. These cells together have detrimental effects on tumor immune surveillance and anti-tumor immunity. Therefore, targeting these regulatory lymphocytes will be crucial in improving treatment outcomes for immunotherapy. Keywords: Breg, CTLA4, FOXP3, Immunotherapy, IL10, PDL1, Treg Background neo-antigens, which are not present in non-cancerous The suppression of anti-tumor immune responses and cells [5]. These neo-antigens offer a clinical advantage augmentation of tumor-promoting immune responses since the tumor cells expressing neo-antigens are then both contribute to tumor progression [1]. -
Express Yourself Immune Evasion by Anthrax
HIGHLIGHTS MACROPHAGES Bacillus anthracis, the causative agent (LPS)-activated macrophages. First, of anthrax, kills macrophages and they showed that LT causes the apop- evades the host immune response by tosis of LPS-treated macrophages; secreting a protein that leads to the then, they investigated the signalling Immune evasion inhibition of p38 mitogen-activated pathways involved. At the concentra- LF protein kinase (p38 MAPK), accord- tion that is required to induce apopto- by anthrax PA ing to a report in Science.The activity sis, LT inhibits the activation of ERK, of this MAPK is required for the c-Jun NH2-terminal kinase 1 (JNK1) transcription of certain downstream and p38, but the activity of JNK2 and nuclear factor-κB (NF-κB) targets. inhibitor of NF-κB (IκB) kinase (IKK) LT Macrophage Three proteins secreted by B. anthr- is unaffected. The authors used spe- acis are important for its pathogenic- cific MAPK inhibitors to determine ity: protective antigen (PA), oedema the contribution of these MAPK cas- factor (EF) and lethal factor (LF). PA cades to LT-induced apoptosis. Only enables EF and LF to enter the cytosol the p38-specific inhibitor (SB202190) of host cells, where EF causes tissue induced apoptosis of LPS-activated oedema and LF acts as a metallopro- macrophages, which indicates that LT X tease, cleaving MAPK kinases (MKKs) might cause apoptosis by inhibiting P and thereby preventing MAPK activa- p38 signalling. MKKs p38 X tion. Lethal toxin (LT; a complex of Macrophages lacking IKK and activated PA and LF) has been shown NF-κB activity were shown to be sen- to be cytotoxic for macrophages, but it sitive to LPS-induced apoptosis also. -
Regulatory T Cell Research
Regulatory T cell research Unique kits for cell isolation Harmonized cell culture and expansion tools Convenient functional assay tools Germany/Austria/ Benelux France Nordics and Baltics South Korea Switzerland Miltenyi Biotec B.V. Miltenyi Biotec SAS Miltenyi Biotec Norden AB Miltenyi Biotec Korea Co., Ltd Reliable flow cytometry analysis Miltenyi Biotec GmbH Schipholweg 68 H 10 rue Mercoeur Scheelevägen 17 Arigi Bldg. 8F Friedrich-Ebert-Straße 68 2316 XE Leiden 75011 Paris, France 223 70 Lund 562 Nonhyeon-ro 51429 Bergisch Gladbach The Netherlands Phone +33 1 56 98 16 16 Sweden Gangnam-gu Germany [email protected] Fax +33 1 56 98 16 17 [email protected] Seoul 06136, South Korea Phone +49 2204 8306-0 Customer service [email protected] Customer service Sweden Phone +82 2 555 1988 Fax +49 2204 85197 The Netherlands Phone 0200-111 800 Fax +82 2 555 8890 [email protected] Phone 0800 4020120 Italy Fax 046-280 72 99 [email protected] Fax 0800 4020100 Miltenyi Biotec S.r.l. Customer service Denmark USA/Canada Customer service Belgium Via Persicetana, 2/D Phone 80 20 30 10 Spain Miltenyi Biotec Inc. Phone 0800 94016 40012 Calderara di Reno (BO) Fax +46 46 280 72 99 Miltenyi Biotec S.L. 2303 Lindbergh Street Fax 0800 99626 Italy Customer service C/Luis Buñuel 2 Auburn, CA 95602, USA Customer service Luxembourg Phone +39 051 6 460 411 Norway, Finland, Iceland, Ciudad de la Imagen Phone 800 FOR MACS Phone 800 24971 Fax +39 051 6 460 499 and Baltic countries 28223 Pozuelo de Alarcón (Madrid) Phone +1 530 888 8871 Fax 800 24984 [email protected] Phone +46 46 280 72 80 Spain Fax +1 877 591 1060 Fax +46 46 280 72 99 Phone +34 91 512 12 90 [email protected] China Japan Fax +34 91 512 12 91 Miltenyi Biotec Technology & Miltenyi Biotec K.K. -
CD8+CD122+Cd49dlow Regulatory T Cells Maintain T-Cell
+ + CD8 CD122 CD49dlow regulatory T cells maintain T-cell homeostasis by killing activated T cells via Fas/FasL-mediated cytotoxicity Kazuyuki Akanea,b, Seiji Kojimab, Tak W. Makc,1, Hiroshi Shikud,e, and Haruhiko Suzukia,1 aDepartment of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan; bDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan; cCampbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre/University Health Network, Toronto, Ontario, Canada M5G 2M9; dDepartment of Cancer Vaccine, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan; and eDepartment of Immuno-Gene Therapy, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan Contributed by Tak W. Mak, January 15, 2016 (sent for review October 5, 2015; reviewed by Toshiaki Ohteki and Heiichiro Udono) The Fas/FasL (CD95/CD178) system is required for immune regula- regulatory action are available. Therefore, it is not clear precisely tion; however, it is unclear in which cells, when, and where Fas/FasL which subset of T cells express FasL or where Fas/FasL-dependent + molecules act in the immune system. We found that CD8+CD122+ CD8 Tregs, if such cells exist, are located and at which point cells, which are mostly composed of memory T cells in compari- they function. Thus, the ultimate pathophysiological role of the + − son with naïve cells in the CD8 CD122 population, were previ- Fas/FasL system is still unknown. ously shown to include cells with regulatory activity and could Regulation of the immune reaction is of pivotal importance be separated into CD49dlow cells and CD49dhigh cells. -
Role of Genomic Variants in the Response to Biologics Targeting Common Autoimmune Disorders
Role of genomic variants in the response to biologics targeting common autoimmune disorders by Gordana Lenert, PhD The thesis submitted to the Faculty of Graduate and Postdoctoral Affairs in partial fulfillment of the requirements for the degree of Master of Science Ottawa-Carleton Joint Program in Bioinformatics Carleton University Ottawa, Canada © 2016 Gordana Lenert Abstract Autoimmune diseases (AID) are common chronic inflammatory conditions initiated by the loss of the immunological tolerance to self-antigens. Chronic immune response and uncontrolled inflammation provoke diverse clinical manifestations, causing impairment of various tissues, organs or organ systems. To avoid disability and death, AID must be managed in clinical practice over long periods with complex and closely controlled medication regimens. The anti-tumor necrosis factor biologics (aTNFs) are targeted therapeutic drugs used for AID management. However, in spite of being very successful therapeutics, aTNFs are not able to induce remission in one third of AID phenotypes. In our research, we investigated genomic variability of AID phenotypes in order to explain unpredictable lack of response to aTNFs. Our hypothesis is that key genetic factors, responsible for the aTNFs unresponsiveness, are positioned at the crossroads between aTNF therapeutic processes that generate remission and pathogenic or disease processes that lead to AID phenotypes expression. In order to find these key genetic factors at the intersection of the curative and the disease pathways, we combined genomic variation data collected from publicly available curated AID genome wide association studies (AID GWAS) for each disease. Using collected data, we performed prioritization of genes and other genomic structures, defined the key disease pathways and networks, and related the results with the known data by the bioinformatics approaches. -
Trim24-Regulated Estrogen Response Is Dependent on Specific Histone Modifications in Breast Cancer Cells
The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 12-2012 TRIM24-REGULATED ESTROGEN RESPONSE IS DEPENDENT ON SPECIFIC HISTONE MODIFICATIONS IN BREAST CANCER CELLS Teresa T. Yiu Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Biochemistry Commons, Cancer Biology Commons, Medicine and Health Sciences Commons, and the Molecular Biology Commons Recommended Citation Yiu, Teresa T., "TRIM24-REGULATED ESTROGEN RESPONSE IS DEPENDENT ON SPECIFIC HISTONE MODIFICATIONS IN BREAST CANCER CELLS" (2012). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 313. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/313 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. TRIM24-REGULATED ESTROGEN RESPONSE IS DEPENDENT ON SPECIFIC HISTONE -
Vaccine Immunology Claire-Anne Siegrist
2 Vaccine Immunology Claire-Anne Siegrist To generate vaccine-mediated protection is a complex chal- non–antigen-specifc responses possibly leading to allergy, lenge. Currently available vaccines have largely been devel- autoimmunity, or even premature death—are being raised. oped empirically, with little or no understanding of how they Certain “off-targets effects” of vaccines have also been recog- activate the immune system. Their early protective effcacy is nized and call for studies to quantify their impact and identify primarily conferred by the induction of antigen-specifc anti- the mechanisms at play. The objective of this chapter is to bodies (Box 2.1). However, there is more to antibody- extract from the complex and rapidly evolving feld of immu- mediated protection than the peak of vaccine-induced nology the main concepts that are useful to better address antibody titers. The quality of such antibodies (e.g., their these important questions. avidity, specifcity, or neutralizing capacity) has been identi- fed as a determining factor in effcacy. Long-term protection HOW DO VACCINES MEDIATE PROTECTION? requires the persistence of vaccine antibodies above protective thresholds and/or the maintenance of immune memory cells Vaccines protect by inducing effector mechanisms (cells or capable of rapid and effective reactivation with subsequent molecules) capable of rapidly controlling replicating patho- microbial exposure. The determinants of immune memory gens or inactivating their toxic components. Vaccine-induced induction, as well as the relative contribution of persisting immune effectors (Table 2.1) are essentially antibodies— antibodies and of immune memory to protection against spe- produced by B lymphocytes—capable of binding specifcally cifc diseases, are essential parameters of long-term vaccine to a toxin or a pathogen.2 Other potential effectors are cyto- effcacy. -
Jci.Org Volume 126 Number 4 April 2016 1239 Commentary the Journal of Clinical Investigation
The Journal of Clinical Investigation COMMENTARY Estrogen turns down “the AIRE” Pearl Bakhru and Maureen A. Su Department of Pediatrics, Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Early clues that sex hormones may Genetic alterations are known drivers of autoimmune disease; however, also modulate thymic stromal populations, there is a much higher incidence of autoimmunity in women, implicating such as mTECs, came from elegant studies sex-specific factors in disease development. The autoimmune regulator that utilized bone marrow chimeras (5, 6). (AIRE) gene contributes to the maintenance of central tolerance, and These studies showed that thymic epitheli- complete loss of AIRE function results in the development of autoimmune al cells express estrogen receptor (ER) and polyendocrinopathy syndrome type 1. In this issue of the JCI, Dragin and androgen receptor (AR) and that expres- colleagues demonstrate that AIRE expression is downregulated in females sion of these hormone receptors in the stromal compartment is required for alter- as the result of estrogen-mediated alterations at the AIRE promoter. The ing bone marrow–derived T cell subsets association between estrogen and reduction of AIRE may at least partially in the thymus (5, 6). In this issue, Dragin account for the elevated incidence of autoimmune disease in women and et al. confirm that sex hormones indeed has potential implications for sex hormone therapy. act on receptors on thymic stromal cells to impinge upon T cell development within the thymus. Furthermore, this study dem- onstrates that sex hormones regulate AIRE Autoimmune disease: autoimmune disease autoimmune poly- expression in mTECs and, in particular, sex-dependent differences endocrinopathy syndrome type 1 (APS1, estrogen decreases AIRE to predispose The incidence of autoimmune disease is which is also known as autoimmune poly- females to autoimmunity (7).